Article

  • The EMBO Journal (2008) 27, 384 - 393
  • doi:10.1038/sj.emboj.7601968

Published online: 10 January 2008

Signaling from bold beta1- and bold beta2-adrenergic receptors is defined by differential interactions with PDE4EMBO Open

Wito Richter1,4, Peter Day2,4, Rani Agrawal3, Matthew D Bruss1, Sébastien Granier2, Yvonne L Wang1, Søren G F Rasmussen2, Kathleen Horner1, Ping Wang1, Tao Lei1, Andrew J Patterson3, Brian Kobilka2 and Marco Conti1

  1. Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA
  2. Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA
  3. Department of Anesthesia, Stanford University School of Medicine, Stanford, CA, USA

Correspondence to:

Marco Conti, Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, Grant Building, Room S301, Stanford, CA 94305-5317, USA. Tel.: +1 650 725 2452; Fax: +1 650 725 7102; E-mail: marco.conti@stanford.edu

4These authors contributed equally to this work

Received 29 June 2007; Accepted 3 December 2007


beta1- and beta2-adrenergic receptors (betaARs) are highly homologous, yet they play clearly distinct roles in cardiac physiology and pathology. Myocyte contraction, for instance, is readily stimulated by beta1AR but not beta2AR signaling, and chronic stimulation of the two receptors has opposing effects on myocyte apoptosis and cell survival. Differences in the assembly of macromolecular signaling complexes may explain the distinct biological outcomes. Here, we demonstrate that beta1AR forms a signaling complex with a cAMP-specific phosphodiesterase (PDE) in a manner inherently different from a beta2AR/beta-arrestin/PDE complex reported previously. The beta1AR binds a PDE variant, PDE4D8, in a direct manner, and occupancy of the receptor by an agonist causes dissociation of this complex. Conversely, agonist binding to the beta2AR is a prerequisite for the recruitment of a complex consisting of beta-arrestin and the PDE4D variant, PDE4D5, to the receptor. We propose that the distinct modes of interaction with PDEs result in divergent cAMP signals in the vicinity of the two receptors, thus, providing an additional layer of complexity to enforce the specificity of beta1- and beta2-adrenoceptor signaling.

  • Keywords:

    • beta-adrenergic receptor,
    • cAMP,
    • cardiac myocyte,
    • cyclic nucleotide phosphodiesterase,
    • PDE

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.

The EMBO Journal is published by Nature Publishing Group on behalf of European Molecular Biology Organization